InfuSystem Holdings, Inc
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $143.4M | $134.9M | $125.8M | $109.9M | $102.4M |
| Gross profit | $80.3M | $70.4M | $63.1M | $60.6M | $58.5M |
| Operating income | $11.9M | $6.9M | $4.1M | $1.7M | $2.8M |
| Operating expenses | $68.4M | $63.5M | $59.0M | $58.9M | $55.7M |
| Cost of revenue | $63.1M | $64.5M | $62.7M | $49.4M | $43.8M |
| Cash from operations | $24.4M | $20.5M | $11.2M | $17.5M | $18.3M |
| Capital expenditure | $560,000 | $1.1M | $1.0M | $982,000 | $980,000 |
| Free cash flow | $23.8M | $19.4M | $10.2M | $16.5M | $17.3M |
| Share repurchases | $9.9M | $1.2M | $153,000 | $5.5M | $560,000 |
| Total assets | $100.6M | $103.6M | $102.9M | $99.4M | $97.6M |
| Total liabilities | $43.2M | $46.1M | $50.6M | $51.4M | $49.3M |
| Total debt | $20.0M | $24.1M | $29.4M | $33.4M | $33.4M |
Shares outstanding 20.2M · Free float 70.4%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.